{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T23:30:56Z","timestamp":1720395056999},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperuricaemia is an undisputed and highly predictive biomarker for cardiovascular risk. <jats:italic>SLC17A1<\/jats:italic>, expressed in the liver and kidneys, harbours potent candidate single nucleotide polymorphisms that decrease uric acid levels. Therefore, we examined <jats:italic>SLC17A1<\/jats:italic> polymorphisms (rs1165196, rs1179086 and rs3757131), which might suppress cardiovascular risk factors and that are involved in liver functioning, via a large-scale pooled analysis of the Japanese general population in a cross-sectional study. Using data from the Japan Multi-Institutional Collaborative Cohort Study, we identified 1842 participants of both sexes, 35\u201369-years-old, having the requisite data and analysed their SLC17A1 genotypes. In men, logistic regression analyses revealed that minor alleles in SLC17A1 polymorphisms (rs1165196 and rs3757131) were associated with a low-\/high-density lipoprotein cholesterol ratio &gt;2.0 (rs1165196: odds ratio [OR], 0.703; 95% confidence interval [CI], 0.536\u20130.922; rs3757131: OR, 0.658; 95% CI, 0.500\u20130.866) and with homocysteine levels of &gt;10.0\u2009nmol\/mL (rs1165196: OR, 0.544; 95% CI, 0.374\u20130.792; rs3757131: OR, 0.509; 95% CI, 0.347\u20130.746). Therefore, these polymorphisms had dominant negative effects on cholesterol homeostasis and hyperhomocysteinaemia, in men, independent of alcohol consumption, physical activity, or daily energy and nutrition intake. Thus, genetic variants of SLC17A1 are potential biomarkers for altered cholesterol homeostasis and hyperhomocysteinaemia in Japanese men.<\/jats:p>","DOI":"10.1038\/srep15888","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T10:04:18Z","timestamp":1446545058000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genetic variants of SLC17A1 are associated with cholesterol homeostasis and hyperhomocysteinaemia in Japanese men"],"prefix":"10.1038","volume":"5","author":[{"given":"Teruhide","family":"Koyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagato","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Oze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Hamajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Wakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rieko","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kokichi","family":"Arisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Shimatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akie","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadao","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"key":"BFsrep15888_CR1","unstructured":"World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. (2007). Available at: http:\/\/www.who.int\/cardiovascular_diseases\/guidelines\/Fulltext.pdf. (Accessed: 21st April 2015)."},{"key":"BFsrep15888_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2741\/3950","volume":"17","author":"M Jin","year":"2012","unstructured":"Jin, M. et al. Uric acid, hyperuricemia and vascular diseases. Front. Biosci. (Landmark Ed). 17, 656\u2013669 (2012).","journal-title":"Front. Biosci."},{"key":"BFsrep15888_CR3","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.2174\/1381612811319130011","volume":"19","author":"D Grassi","year":"2013","unstructured":"Grassi, D. et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr. Pharm. Des. 19, 2432\u20132438 (2013).","journal-title":"Curr. Pharm. Des."},{"key":"BFsrep15888_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/art.24612","volume":"61","author":"SY Kim","year":"2009","unstructured":"Kim, S. Y. et al. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 61, 885\u2013892 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFsrep15888_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nygard","year":"1997","unstructured":"Nygard, O. et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337, 230\u2013236 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep15888_CR6","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1038\/srep05663","volume":"4","author":"T Okura","year":"2014","unstructured":"Okura, T. et al. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Sci. Rep. 4, 5663 (2014).","journal-title":"Sci. Rep."},{"key":"BFsrep15888_CR7","first-page":"68","volume":"5","author":"O Micle","year":"2012","unstructured":"Micle, O., Muresan, M., Antal, L., Bodog, F. & Bodog, A. The influence of homocysteine and oxidative stress on pregnancy outcome. J. Med. Life. 5, 68\u201373 (2012).","journal-title":"J. Med. Life."},{"key":"BFsrep15888_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrcardio.2010.223","volume":"8","author":"BJ Arsenault","year":"2011","unstructured":"Arsenault, B. J., Boekholdt, S. M. & Kastelein, J. J. Lipid parameters for measuring risk of cardiovascular disease. Nat. Rev. Cardiol. 8, 197\u2013206 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"BFsrep15888_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature04399","volume":"438","author":"FR Maxfield","year":"2005","unstructured":"Maxfield, F. R. & Tabas, I. Role of cholesterol and lipid organization in disease. Nature. 438, 612\u2013621 (2005).","journal-title":"Nature."},{"key":"BFsrep15888_CR10","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285, 2486\u20132497 (2001).","DOI":"10.1001\/jama.285.19.2486"},{"key":"BFsrep15888_CR11","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone, N. J. et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 129 (suppl 2), S1\u2013S45 (2014).","journal-title":"Circulation."},{"key":"BFsrep15888_CR12","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff Jr.","year":"2014","unstructured":"Goff, D. C., Jr. et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 129 (Suppl 2), S49\u2013S73 (2014).","journal-title":"Circulation."},{"key":"BFsrep15888_CR13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/0002-8703(85)90224-8","volume":"110","author":"WB Kannel","year":"1985","unstructured":"Kannel, W. B. Lipids, diabetes and coronary heart disease: insights from the Framingham Study. Am. Heart J. 110, 1100\u20131107 (1985).","journal-title":"Am. Heart J."},{"key":"BFsrep15888_CR14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/jama.298.7.776","volume":"298","author":"E Ingelsson","year":"2007","unstructured":"Ingelsson, E. et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 298, 776\u2013785 (2007).","journal-title":"JAMA."},{"key":"BFsrep15888_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.humimm.2012.05.004","volume":"73","author":"YH Lee","year":"2012","unstructured":"Lee, Y. H. & Song, G. G. Pathway analysis of genome-wide association studies on uric acid concentrations. Hum. Immunol. 73, 805\u2013810 (2012).","journal-title":"Hum. Immunol."},{"key":"BFsrep15888_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.mam.2012.05.004","volume":"34","author":"RJ Reimer","year":"2013","unstructured":"Reimer, R. J. SLC17: a functionally diverse family of organic anion transporters. Mol. Aspects Med. 34, 350\u2013359 (2013).","journal-title":"Mol. Aspects Med."},{"key":"BFsrep15888_CR17","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1073\/pnas.93.11.5347","volume":"93","author":"AE Busch","year":"1996","unstructured":"Busch, A. E. et al. Expression of a renal type I sodium\/phosphate transporter (NaPi-1) induces a conductance in Xenopus oocytes permeable for organic and inorganic anions. Proc. Natl. Acad. Sci. USA. 93, 5347\u20135351 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFsrep15888_CR18","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/ard.2008.106856","volume":"69","author":"W Urano","year":"2010","unstructured":"Urano, W. et al. Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann. Rheum. Dis. 69, 1232\u20131234 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFsrep15888_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/rheumatology\/kep332","volume":"49","author":"E Roddy","year":"2010","unstructured":"Roddy, E., Mallen, C. D., Hider, S. L. & Jordan, K. P. Prescription and comorbidity screening following consultation for acute gout in primary care. Rheumatology (Oxford). 49, 105\u2013111 (2010).","journal-title":"Rheumatology (Oxford)."},{"key":"BFsrep15888_CR20","doi-asserted-by":"publisher","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz, M. et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 5, e1000504 (2009).","journal-title":"PLoS Genet."},{"key":"BFsrep15888_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","volume":"3","author":"Q Yang","year":"2010","unstructured":"Yang, Q. et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ. Cardiovasc. Genet. 3, 523\u2013530 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFsrep15888_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/art.23121","volume":"58","author":"AG Ioachimescu","year":"2008","unstructured":"Ioachimescu, A. G., Brennan, D. M., Hoar, B. M., Hazen, S. L. & Hoogwerf, B. J. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 58, 623\u2013630 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFsrep15888_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(14)61009-6","volume":"384","author":"PM Ridker","year":"2014","unstructured":"Ridker, P. M. LDL cholesterol: controversies and future therapeutic directions. Lancet. 384, 607\u2013617 (2014).","journal-title":"Lancet."},{"key":"BFsrep15888_CR24","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa050461","volume":"352","author":"JC LaRosa","year":"2005","unstructured":"LaRosa, J. C. et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N. Engl. J. Med. 352, 1425\u20131435 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep15888_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.297.5.499","volume":"297","author":"SJ Nicholls","year":"2007","unstructured":"Nicholls, S. J. et al. Statins, high-density lipoprotein cholesterol and regression of coronary atherosclerosis. JAMA. 297, 499\u2013508 (2007).","journal-title":"JAMA."},{"key":"BFsrep15888_CR26","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3346\/jkms.2014.29.6.788","volume":"29","author":"ST Choi","year":"2014","unstructured":"Choi, S. T., Kim, J. S. & Song, J. S. Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients. J. Korean Med. Sci. 29, 788\u2013792 (2014).","journal-title":"J. Korean Med. Sci."},{"key":"BFsrep15888_CR27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","volume":"99","author":"D Liao","year":"2006","unstructured":"Liao, D. et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ. Res. 99, 598\u2013606 (2006).","journal-title":"Circ. Res."},{"key":"BFsrep15888_CR28","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.febslet.2009.03.038","volume":"583","author":"R Obeid","year":"2009","unstructured":"Obeid, R. & Herrmann, W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS. Lett. 583, 1215\u20131225 (2009).","journal-title":"FEBS. Lett."},{"key":"BFsrep15888_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0021-9150(00)00738-3","volume":"157","author":"K Kario","year":"2001","unstructured":"Kario, K. et al. High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage. Atherosclerosis. 157, 441\u2013449 (2001).","journal-title":"Atherosclerosis."},{"key":"BFsrep15888_CR30","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1371\/journal.pmed.0020135","volume":"2","author":"MR Olthof","year":"2005","unstructured":"Olthof, M. R., van Vliet, T., Verhoef, P., Zock, P. L. & Katan, M. B. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans. PLoS Med. 2, e135 (2005).","journal-title":"PLoS Med."},{"key":"BFsrep15888_CR31","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMoa060900","volume":"354","author":"E Lonn","year":"2006","unstructured":"Lonn, E. et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354, 1567\u20131577 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep15888_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/BOR.0b013e3282f33f87","volume":"20","author":"A Taniguchi","year":"2008","unstructured":"Taniguchi, A. & Kamatani, N. Control of renal uric acid excretion and gout. Curr. Opin. Rheumatol. 20, 192\u2013197 (2008).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFsrep15888_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","volume":"131","author":"BF Culleton","year":"1999","unstructured":"Culleton, B. F., Larson, M. G., Kannel, W. B. & Levy, D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann. Intern. Med. 131, 7\u201313 (1999).","journal-title":"Ann. Intern. Med."},{"key":"BFsrep15888_CR34","first-page":"317","volume":"8","author":"N Hamajima","year":"2007","unstructured":"Hamajima, N. The Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) to detect gene-environment interactions for cancer. Asian Pac. J. Cancer Prev. 8, 317\u2013323 (2007).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"BFsrep15888_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2188\/jea.JE20100139","volume":"21","author":"K Wakai","year":"2011","unstructured":"Wakai, K. et al. Profile of participants and genotype distributions of 108 polymorphisms in a cross-sectional study of associations of genotypes with lifestyle and clinical factors: a project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study. J. Epidemiol. 21, 223\u2013235 (2011).","journal-title":"J. Epidemiol."},{"key":"BFsrep15888_CR36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499\u2013502 (1972).","journal-title":"Clin. Chem."},{"key":"BFsrep15888_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2188\/jea.17.100","volume":"17","author":"N Imaeda","year":"2007","unstructured":"Imaeda, N. et al. Reproducibility of a short food frequency questionnaire for Japanese general population. J. Epidemiol. 17, 100\u2013107 (2007).","journal-title":"J. Epidemiol."},{"key":"BFsrep15888_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2188\/jea.15.135","volume":"15","author":"Y Tokudome","year":"2005","unstructured":"Tokudome, Y. et al. Relative validity of a short food frequency questionnaire for assessing nutrient intake versus three-day weighed diet records in middle-aged Japanese. J. Epidemiol. 15, 135\u2013145 (2005).","journal-title":"J. Epidemiol."},{"key":"BFsrep15888_CR39","first-page":"40","volume":"5","author":"S Tokudome","year":"2004","unstructured":"Tokudome, S. et al. Development of a data-based short food frequency questionnaire for assessing nutrient intake by middle-aged Japanese. Asian Pac. J. Cancer Prev. 5, 40\u201343 (2004).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"BFsrep15888_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/11026480600568720","volume":"50","author":"C Goto","year":"2006","unstructured":"Goto, C. et al. Validation study of fatty acid consumption assessed with a short food frequency questionnaire against plasma concentration in middle-aged Japanese people. Scand. J. Nutr. 50, 77\u201382 (2006).","journal-title":"Scand. J. Nutr."},{"key":"BFsrep15888_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2188\/jea.JE20120078","volume":"22","author":"M Hara","year":"2012","unstructured":"Hara, M. et al. Effect of the PPARG2 Pro12Ala polymorphism and clinical risk factors for diabetes mellitus on HbA1c in the Japanese general population. J. Epidemiol. 22, 523\u2013531 (2012).","journal-title":"J. Epidemiol."},{"key":"BFsrep15888_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s100380170047","volume":"46","author":"Y Ohnishi","year":"2001","unstructured":"Ohnishi, Y. et al. A high-throughput SNP typing system for genome-wide association studies. J. Hum. Genet. 46, 471\u2013477 (2001).","journal-title":"J. Hum. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep15888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep15888","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep15888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T13:51:17Z","timestamp":1672926677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep15888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]}},"alternative-id":["BFsrep15888"],"URL":"https:\/\/doi.org\/10.1038\/srep15888","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]},"assertion":[{"value":"7 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15888"}}